Furthermore, its immunological mechanism was revealed by a randomized double-blind multicentre study in which omalizumab treatment was effective in reducing the IgE levels in respiratory tract mucosa and blood, as well as the number of eosinophils, for patients with asthma [19]. The gene discussed is IGHE; the disease is asthma.